To mark World Pharmacist Day on Friday 25 September 2026, Rosie Marchant, Pharmacist Clinical Lead at Health Innovation West of England, reflects on her career as a pharmacist, her journey to becoming Clinical Lead for our work as part of the Health Innovation Network’s on-going cluster, Preventing Problematic Polypharmacy, and how the programme is helping…
Read more
Marking the publication of Health Innovation West of England’s new impact report for 2025-26, our Chair and Vice-Chancellor of the University of the West of England, Steve West, and our Chief Executive, Natasha Swinscoe, reflect on a year of transformative progress in embedding innovation into everyday care. Over the past year, Health Innovation West of…
Read more
In the latest in our series of interviews with members of the Health Innovation West of England team, we talk to Senior Programme Manager, Jan Scott, who leads our patient safety programmes. Jan reflects on her career so far, the work she’s passionate about, and the impact in patient safety we’re collectively striving to make across…
Read more
Chris Learoyd is Senior Project Manager at the West of England AHSN, overseeing our medicines optimisation programmes. In this blog, Chris explores some of the work we are currently involved in to help reduce harm from medicines. Medicines safety and improvement work is complex: patients are prescribed medicines in different settings across the entire healthcare…
Read more
Ahead of World Patient Safety Day 2022, Jan Scott, Patient Safety Programme Manager, discusses how the West of England AHSN Polypharmacy Community of Practice (CoP) is tackling the challenge to reduce severe avoidable medication related harm. The AHSN held its first CoP in August 2022 with the second scheduled for November. Polypharmacy simply means many…
Read more
The AHSN Network recently launched the new national polypharmacy programme: getting the balance right. Here national Programme Manager, Amy Semple and Clinical Lead, Clare Howard discuss why we need to take action to address problematic polypharmacy and how the AHSN Network is supporting this important area of work. “As we live longer with more long-term…
Read more
Mark Gregory, our Lead Pharmacist, reflects on the risks associated with polypharmacy and the benefits of deprescribing. In 1995 only 2% of the population over the age of 65 years were prescribed 10 or more medicines. By 2010 this figure had increased to 5% and by 2018 increased further to 8%. For those over the…
Read moreHealth Innovation West of England is part of the Royal United Hospitals Bath Foundation Trust. Health Innovation West of England is not responsible for the content of external sites. Read about our links to external sites.
